Cycloartenyl ferulate improves natural killer (NK) cell immunity against cancer by binding to IFNγ receptor 1

J Biol Chem. 2023 Aug;299(8):104990. doi: 10.1016/j.jbc.2023.104990. Epub 2023 Jun 29.

Abstract

Cycloartenyl ferulate (CF) is abundant in brown rice with multiple biologic functions. It has been reported to possess antitumor activity; however, the related mechanism of action of CF has not been clarified. Herein, we unexpectedly uncover the immunological regulation effects of CF and its molecular mechanism. We discovered that CF directly enhanced the killing capacity of natural killer (NK) cells for various cancer cells in vitro. In vivo, CF also improved cancer surveillance in mouse models of lymphoma clearance and metastatic melanoma dependent on NK cells. In addition, CF promoted anticancer efficacy of the anti-PD1 antibody with improvement of tumor immune microenvironment. Mechanistically, we first unveiled that CF acted on the canonical JAK1/2-STAT1 signaling pathway to enhance the immunity of the NK cells by selectively binding to interferon γ receptor 1. Collectively, our results indicate that CF is a promising immunoregulation agent worthy of attention in clinical application in the future. Due to broad biological significance of interferon γ, our findings also provide a capability to understand the diverse functions of CF.

Keywords: IFNγ receptor; NK cell; cancer; cycloartenyl ferulate; immunology; signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Coumaric Acids* / pharmacology
  • Interferon gamma Receptor
  • Interferon-gamma / immunology
  • Killer Cells, Natural* / drug effects
  • Killer Cells, Natural* / immunology
  • Mice
  • Neoplasms* / immunology
  • Receptors, Interferon* / immunology
  • Tumor Microenvironment

Substances

  • cycloartenyl ferulate
  • Interferon-gamma
  • Coumaric Acids
  • Receptors, Interferon